Key result
Cardiometabolic syndrome is linked to increased risk of CHD, ischemic stroke, and overall mortality.
Why the study?
The cardiometabolic syndrome is prevalent and epidemiologically linked to increased risk of coronary heart disease, stroke, cardiovascular mortality, and cardiac dysfunction.
The cardiometabolic syndrome is a significant risk factor for various cardiovascular diseases, and imaging modalities can help define this risk.
Cardiometabolic syndrome signals higher CV mortality and AF risk; leaves open whether imaging refines management or outcomes.
The cardiometabolic syndrome is a prevalent metabolic disorder. Epidemiologic studies correlate the cardiometabolic syndrome with an increased risk of coronary heart disease, ischemic stroke, cardiovascular mortality, and total mortality. There is also evidence that the cardiometabolic syndrome is a risk factor for abnormalities in myocardial metabolism, cardiac dysfunction, and arrhythmias such as atrial fibrillation. Multiple imaging modalities, both invasive and noninvasive, may help physicians better define the presence or risk of cardiovascular disease in their patients with the cardiometabolic syndrome.
No takes yet. Share an insight, caveat, or question.
Ash‐Bernal et al. (2006) conducted a review in Cardiometabolic syndrome and cardiovascular disease. Cardiometabolic syndrome was evaluated. The cardiometabolic syndrome is correlated with an increased risk of coronary heart disease, ischemic stroke, cardiovascular mortality, and total mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: